ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,895Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 448

$1.76M Total Retail Price of All Prescriptions

Rank: 6 out of 448

1,026 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 1,026 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 10,872 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 45%.

Prescription Price

$127 was the average price of a prescription from this provider, compared to $111 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 993 797 1 1
SIMVASTATIN 851 675 2 4
METFORMIN HCL 746 589 3 2
LANTUS 556 416 4 8
GLIMEPIRIDE 526 435 5 7
LANTUS SOLOSTAR 455 309 6 10
PEN NEEDLE 414 323 7 5
HUMALOG 398 300 8 11
JANUVIA 377 309 9 6
AMLODIPINE BESYLATE 334 277 10 12
INSULIN SYRINGE 330 293 11 9
ATORVASTATIN CALCIUM 318 268 12 13
JANUMET 314 203 13 32
CRESTOR 299 238 14 22
NOVOLOG 275 183 15 34
NOVOLOG FLEXPEN 264 169 16 28
METHIMAZOLE 255 220 17 24
SYNTHROID 240 182 18 3
LOSARTAN POTASSIUM 230 186 19 16
FENOFIBRATE 221 162 20 59
LISINOPRIL 213 164 21 14
DIOVAN 211 177 22 23
ACTOS 207 174 23 20
ZETIA 168 103 24 41
DIOVAN HCT 154 132 25 61
LOVAZA 153 103 26 43
LEVEMIR FLEXPEN 152 124 27 35
HYDROCHLOROTHIAZIDE 134 112 28 27
BENAZEPRIL HCL 127 104 29 38
CARVEDILOL 117 103 30 36
ALENDRONATE SODIUM 108 103 31 17
SURE COMFORT 107 83 32 78
ONGLYZA 105 67 33 58
GABAPENTIN 98 79 34 30
LEVOXYL 97 80 35 18
FUROSEMIDE 93 78 36 25
ACTOPLUS MET 93 79 36 117
NOVOLOG MIX 70-30 88 71 38 82
LOSARTAN-HYDROCHLOROTHIAZIDE 86 70 39 50
EXFORGE 85 83 40 105
BYETTA 84 44 41 47
NIASPAN 75 40 42 92
RAMIPRIL 74 65 43 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 22 43 96
LIPITOR 74 66 43 56
TRICOR 66 42 46 106
PIOGLITAZONE HCL 65 49 R 47 66
METFORMIN HCL ER 61 44 48 19
VICTOZA 3-PAK 59 32 49 64
ATENOLOL 56 53 50 29
NOVOLOG MIX 70-30 FLEXPEN 55 51 51 74
SPIRONOLACTONE 51 41 52 110
METOPROLOL SUCCINATE 50 45 53 39
LEVEMIR 50 31 53 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.